Exact Mass: 307.2735818

Fingolimod

2-amino-2-(2-(4-Octylphenyl)ethyl)-1,3-propanediol hydrochloride

L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants > L04AA - Selective immunosuppressants D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents > D000081243 - Sphingosine 1 Phosphate Receptor Modulators COVID info from Guide to PHARMACOLOGY, DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials C308 - Immunotherapeutic Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Pumiliotoxin A

6-(6-hydroxy-2,5-dimethyloct-4-en-1-ylidene)-8-methyl-hexahydroindolizin-8-ol

2-hydroxy-2-methyl-N-{trans-1-methyl-4-[(2E,4E)-6-methylhepta-2,4-dien-2-yl]cyclohexyl}-propanamide

2E,4E-hexadecadienoic acid isobutylamide|hexadeca-2t,4t-dienoic acid isobutylamide|Hexadeca-2t,4t-diensaeure-isobutylamid|N-isobutyl-(2E,4E)-hexadeca-2,4-dienamide|N-isobutyl-2E,4E-hexadecadienamide|N-Isobutylhexadeca-trans-2,trans-4-dienamid

octahydro-6-(4-hydroxy-2,5-dimethyl-5-octenylidene)-8-methyl-8-indolizinol

C20H37NO

albizzine A

C17H29N3O2 (307.2259654)

cylindricine C

3-O-Tetradecanoyl-1-cyano-2-methyl-1-propene

(8S,Z)-6-((2R,E)-4-hydroxy-2,5-dimethyloct-5-en-1-ylidene)-8-methyloctahydroindolizin-8-ol

(2R)-1-((8S,Z)-8-hydroxy-8-methylhexahydroindolizin-6(5H)-ylidene)-2,5-dimethyloctan-4-one

(7R)-8-((8S,Z)-8-hydroxy-8-methylhexahydroindolizin-6(5H)-ylidene)-4,7-dimethyloctan-3-one

(8S,Z)-6-((2R,E)-6-hydroxy-2,5-dimethyloct-4-en-1-ylidene)-8-methyloctahydroindolizin-8-ol

(8S,Z)-6-((2R,E)-7-hydroxy-2,5-dimethyloct-4-en-1-ylidene)-8-methyloctahydroindolizin-8-ol

(7R,8R,E)-6-((R,E)-2,5-dimethyloct-4-en-1-ylidene)-8-methyloctahydroindolizine-7,8-diol

FTY720

2-amino-2-[2-(4-octylphenyl)ethyl]-1,3-propanediol, hydrochloride

R-Dysidazirine

methyl 3-(pentadec-1E-enyl)-2H-azirine-2S-carboxylate

C20H25D5O2 (307.25595388999994)

Eicosapentaenoic Acid-d5

EPA (d5)

5Z,8Z,11Z,14Z,17Z-eicosapentaenoic acid (d5)

C20H25D5O2 (307.25595388999994)

N-(2,6-dicyclohexyloxan-4-yl)acetamide

Amoxecaine

C17H29N3O2 (307.2259654)

sodium N-tetradecyl-beta-alaninate

C17H34NNaO2 (307.2487104)

1,7,7-trimethyl-N,N-bis(2-methylpropyl)-2-oxo-4-bicyclo[2.2.1]heptanecarboxamide

6-(Octahydro-1H-indol-1-ylmethyl)decahydroquinazoline-2,4-diamine

C17H33N5 (307.2735818)

(11Z,14Z)-Icosadienoate

A polyunsaturated fatty acid anion that is the conjugate base of (11Z,14Z)-icosadienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

(8Z,11Z)-Eicosa-8,11-dienoate

10,13-Epoxy-11-methyl-octadecadienoate

C19H31O3- (307.2273076)

An 11,13-eicosadienoate

(11E,13Z)-eicosadienoate

(11Z,13E)-eicosadienoate

(11E,13E)-eicosa-11,13-dienoate

(11Z, 13Z)-icosa-11,13-dienoate

Octahydro-6-(6-hydroxy-2,5-dimethyl-4-octen-1-ylidene)-8-methylindolizin-8-ol

(6Z,8S)-6-[(E,6S)-6-hydroxy-2,5-dimethyloct-4-enylidene]-8-methyl-1,2,3,5,7,8a-hexahydroindolizin-8-ol

(11Z,14Z)-eicosadienamide

(5Z,8Z)-eicosadienoate

(2E,4E)-icosa-2,4-dienoate

Perhydro-histrionicotoxin, 1,2-dedihydro-, methyl(ether)

icosadienoate

C20H35O2 (307.263691)

A polyunsaturated fatty acid anion that is the conjugate base of icosadienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

(8Z,11Z)-icosadienoate(1-)

C20H35O2 (307.263691)

An icosadienoate obtained by deprotonation of the carboxy group of (8Z,11Z)-icosadienoic acid; major species at pH 7.3.

NA-Histamine 13:0

C18H33N3O (307.2623488)

methyl (2r)-3-[(1e)-pentadec-1-en-1-yl]-2h-azirine-2-carboxylate

methyl 3-(pentadec-1-en-1-yl)-2h-azirine-2-carboxylate

1-(pyrrolidin-1-yl)hexadec-4-en-1-one